InvestorsObserver
×
News Home

What is the Market's View on Abeona Therapeutics Inc (ABEO) Stock's Price and Volume Trends Monday?

Monday, March 18, 2024 10:33 AM | InvestorsObserver Analysts

Mentioned in this article

What is the Market's View on Abeona Therapeutics Inc (ABEO) Stock's Price and Volume Trends Monday?

Abeona Therapeutics Inc (ABEO) stock is lower by 6.02% over the past week and gets a Bullish rating from InvestorsObserver Sentiment Indicator.

Sentiment Score - ,bullish
Abeona Therapeutics Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on ABEO!

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score. As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend. Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down. InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend. Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.

What's Happening With ABEO Stock Today?

Abeona Therapeutics Inc (ABEO) stock has fallen -14.95% while the S&P 500 has gained 1.07% as of 10:20 AM on Monday, Mar 18. ABEO has fallen -$1.29 from the previous closing price of $8.63 on volume of 401,882 shares. Over the past year the S&P 500 has risen 30.88% while ABEO has gained 219.13%. ABEO lost -$2.02 per share in the over the last 12 months.

More About Abeona Therapeutics Inc

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Click Here to get the full Stock Report for Abeona Therapeutics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App